Can exhaled nitric oxide (FeNO) predict radiotherapy-induced lung toxicity in lung cancer patients? Source: Annual Congress 2011 - Palliation and morbidity in lung cancer patients Year: 2011
Measurement of alveolar nitric oxide in patients with lung cancer Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012
The source of exhaled nitric oxide does not correlate with clinical markers in interstitial lung disease Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease Year: 2007
Extended measurement of exhaled nitric oxide in patients after lung transplantation Source: Eur Respir J 2005; 26: Suppl. 49, 705s Year: 2005
Bronchodilator response and previous lung function decline in relation with exhaled nitric oxide levels in asthma Source: International Congress 2017 – Monitoring novel biomarkers in asthma Year: 2017
Utility of fractional exhaled nitric oxide suppression as a prediction tool for progression to biologic therapy Source: ERJ Open Res, 7 (3) 00273-2021; 10.1183/23120541.00273-2021 Year: 2021
The impact of lung cancer subtypes, smoking status and corticosteroid treatment on exhaled nitric oxide levels in patients with lung cancer Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014
Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients Source: Eur Respir J 2008; 31: 539-546 Year: 2008
Different relation between exhaled nitric oxide and lung function with regard to current smoking Source: International Congress 2018 – Epidemiology of asthma, COPD and factors that associate with lung function Year: 2018
Antibiotic treatment decreases exhaled nitric oxide levels in cystic fibrosis patients Source: Eur Respir J 2004; 24: Suppl. 48, 384s Year: 2004
Utility of exhaled nitric oxide as a noninvasive biomarker of lung inflammation in a disease model Source: Eur Respir J 2006; 28: 1236-1244 Year: 2006
Self-reported asthma control correlates with fraction of exhaled nitric oxide and lung function Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009
The oropharyngeal contribution to exhaled nitric oxide (eNO) levels Source: Eur Respir J 2001; 18: Suppl. 33, 460s Year: 2001
Biomarkers of human asthma; the effect of inhaled AMP on exhaled nitric oxide and circulating VEGF levels Source: Eur Respir J 2005; 26: Suppl. 49, 229s Year: 2005
Elevated exhaled nitric oxide and risk of wheezing in infancy. The generation R study Source: Annual Congress 2009 - New developments in preschool wheezing disorders and its genetic basis Year: 2009
Clinical usefulness of fractional exhaled nitric oxide (FeNO) as a marker of long-term asthma control Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009
Fractionated exhaled nitric oxide in COPD patients Source: International Congress 2019 – Advances in clinical management of COPD Year: 2019
Fractional exhaled nitric oxide (FeNO) suppression with directly observed inhaled corticosteroid therapy: does it make a difference to patient outcomes? Source: International Congress 2018 – Clinical and functional monitoring in airway disease Year: 2018
Changes in the ratios of stable nitric oxide metabolites in the exhaled breath condensate in patients with COPD during antioxidant therapy. Source: International Congress 2019 – Oxidative stress, hypoxia and microbial exposure in the pathogenesis of pulmonary disease Year: 2019
Time course of exhaled hydrogen peroxide (H2 O2 ) and nitric oxide (eNO) during chemotherapy in patients with lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 92s Year: 2005